Unknown

Dataset Information

0

Predictive hyperglycemia and hypoglycemia minimization: In-home double-blind randomized controlled evaluation in children and young adolescents.


ABSTRACT: OBJECTIVE:The primary objective of this trial was to evaluate the feasibility, safety, and efficacy of a predictive hyperglycemia and hypoglycemia minimization (PHHM) system vs predictive low glucose suspension (PLGS) alone in optimizing overnight glucose control in children 6 to 14 years old. RESEARCH DESIGN AND METHODS:Twenty-eight participants 6 to 14 years old with T1D duration ?1?year with daily insulin therapy ?12 months and on insulin pump therapy for ?6?months were randomized per night into PHHM mode or PLGS-only mode for 42 nights. The primary outcome was percentage of time in sensor-measured range 70 to 180?mg/dL in the overnight period. RESULTS:The addition of automated insulin delivery with PHHM increased time in target range (70-180?mg/dL) from 66?±?11% during PLGS nights to 76?±?9% during PHHM nights (P<.001), without increasing hypoglycemia as measured by time below various thresholds. Average morning blood glucose improved from 176?±?28?mg/dL following PLGS nights to 154?±?19?mg/dL following PHHM nights (P<.001). CONCLUSIONS:The PHHM system was effective in optimizing overnight glycemic control, significantly increasing time in range, lowering mean glucose, and decreasing glycemic variability compared to PLGS alone in children 6 to 14 years old.

SUBMITTER: Forlenza GP 

PROVIDER: S-EPMC5951790 | biostudies-literature | 2018 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Objective</h4>The primary objective of this trial was to evaluate the feasibility, safety, and efficacy of a predictive hyperglycemia and hypoglycemia minimization (PHHM) system vs predictive low glucose suspension (PLGS) alone in optimizing overnight glucose control in children 6 to 14 years old.<h4>Research design and methods</h4>Twenty-eight participants 6 to 14 years old with T1D duration ≥1 year with daily insulin therapy ≥12 months and on insulin pump therapy for ≥6 months were randomi  ...[more]

Similar Datasets

| S-EPMC5319476 | biostudies-literature
| S-EPMC2768200 | biostudies-literature
| S-EPMC3387889 | biostudies-literature
| S-EPMC5540519 | biostudies-literature
| S-EPMC4026396 | biostudies-literature
| S-EPMC7174034 | biostudies-literature
| S-EPMC7560934 | biostudies-literature
| S-EPMC4477332 | biostudies-literature
| S-EPMC4432491 | biostudies-literature
| S-EPMC5748004 | biostudies-literature